This item is authorised by the following title:
Disallowed in Part
National Health (Pharmaceutical Benefits—Therapeutic Groups) Determination 2020 (PB 29 of 2020)
When documents are presented to the Australian Parliament for scrutiny, they are said to have been tabled.
This legislative instrument has been subject to a Motion to Disallow
Disallowed in Part